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Prolactin-releasing peptide (PrRP) is one of the RF-amide peptides and was originally
identified in the bovine hypothalamus as a stimulator of prolactin (PRL) release. Inde-
pendently, another RF-amide peptide was found in Japanese crucian carp and named
Carassius-RFa (C-RFa), which shows high homology to PrRP and stimulates PRL secre-
tion in teleost fish. Therefore, C-RFa has been recognized as fish PrRP. However, recent
work has revealed that PrRP and C-RFa in non-mammalian vertebrates are encoded by
separate genes originated through duplication of an ancestral gene. Indeed, both PrRP and
C-RFa are suggested to exist in teleost, amphibian, reptile, and avian species. Therefore,
we propose that non-mammalian PrRP (C-RFa) be renamed PrRP2. Despite a common
evolutionary origin, PrRP2 appears to be a physiological regulator of PRL, whereas this
is not a consistent role for PrRP itself. Further work revealed that the biological functions
of PrRP and PrRP2 are not limited solely to PRL release, because they are also neuro-
modulators of several hypothalamus–pituitary axes and are involved in some brain circuits
related to the regulation of food intake, stress, and cardiovascular functions. However,
these actions appear to be different among vertebrates. For example, central injection
of PrRP inhibits feeding behavior in rodents and teleosts, while it stimulates it in chicks.
Therefore, both PrRP and PrRP2 have acquired diverse actions through evolution. In this
review, we integrate the burgeoning information of structures, expression profiles, and
multiple biological actions of PrRP in higher vertebrates, as well as those of PrRP2 in
non-mammals.
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DISCOVERY OF PROLACTIN-RELEASING PEPTIDES
Hinuma et al. (1) first identified a peptide, which is a ligand of
the orphan 7-transmembrane receptor hGR3, by using a reverse-
pharmacological technique. The peptide was named “prolactin-
releasing peptide (PrRP)” because it was found to specifically
promote prolactin (PRL) release from rat anterior pituitary cells
in vitro.
Independent of the discovery of mammalian PrRP, a novel
RF-amide peptide, which has a similar amino acid sequence,
was isolated from the brain of the Japanese crucian carp using
an intestine contracting assay (2) and named Carassius-RFa
(C-RFa). In addition to the sequence homology, C-RFa is a
strong candidate as the stimulator of PRL synthesis and release,
and this peptide has been regarded as a teleost PrRP. How-
ever, some studies reported that PrRP did not show a PRL-
releasing effect in mammals (3). These differences implied that
PrRP and C-RFa might not be orthologous. Finally, with a
synteny analysis, Lagerström et al. (4) and Wang et al. (5)
found that PrRP and C-RFa originated in gene duplication
from a common ancestral gene, and we propose that the widely
used name of PrRP in lower vertebrate species be renamed
“PrRP2.”
BIOCHEMISTRY AND MOLECULAR BIOLOGY OF PrRP AND
PrRP2
PrRP
Prolactin-releasing peptide was first identified in the bovine hypo-
thalamus (1). There are two types of PrRP in mammals: one
consists of 20 amino acids (PrRP-20) and the other consists of
31 amino acids (PrRP-31) (Figure 1), with PrRP-20 being a C-
terminal fragment of PrRP-31. As well as in mammals, PrRP-20 is
also predicted from the cDNA sequences in some non-mammalian
vertebrates, such as chicken, Xenopus tropicalis, and zebrafish (5),
while the existence of a longer form of PrRP such as PrRP-31 has
been unclear (Figure 1). These amino acid sequences of PrRP-20
are well conserved. Among mammals, rat and mouse PrRP-20 are
identical and their amino acid sequence shows high homology to
bovine and human counterparts. Chicken and X. tropicalis have
the same PrRP-20, whose sequence is different from murine PrRP-
20 at only three amino acids. The amino acid sequence of zebrafish
PrRP-20 shows moderate homology to those of mammals, and of
chicken or X. tropicalis. All PrRPs have the Arg-Phe-NH2 (RF-
amide) motif at the C-terminus. The C-terminus amidation is
necessary for interaction with the receptors because PrRP-20 with
a non-amidated C-terminus cannot efficiently interact (1). Rat and
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【PrRP】
Rat PrRP SRAHQHSMETRTPDINPAWYTGRGIRPVGRF-NH2
Mouse PrRP SRAHQHSMETRTPDINPAWYTGRGIRPVGRF-NH2
Bovine PrRP SRAHQHSMEIRTPDINPAWYAGRGIRPVGRF-NH2
Human PrRP SRTHRHSMEIRTPDINPAWYASRGIRPVGRF-NH2
Chicken PrRP NPDIDPSWYTGRGIRPVGRF-NH2
Turtle PrRP NPDIDPSWYTGRGIRPVGRF-NH2
Frog PrRP NPDIDPSWYTGRGIRPVGRF-NH2
Zebrafish PrRP DPNIDAMWYKDRGIRPVGRF-NH2
Lamprey RFa-A SASNAGSDINPEWYFGRGVRPIGRF-NH2
【PrRP2】
Chicken PrRP2 SRPFKHQIDNRSPEIDPFWYVGRGVRPIGRF-NH2
Alligator PrRP2 SRSFKHQIDNRSPEIDPFWYVGRGVRPIGRF-NH2
Frog PrRP2 SRSFNHQIDNRSPEIDPYWYVGRGVRPIGRF-NH2
Zebrafish PrRP2 SPEIDPFWYVGRGVRPIGRF-NH2
Crucian carp PrRP2 SPEIDPFWYVGRGVRPIGRF-NH2
Salmon PrRP2 SPEIDPFWYVGRGVRPIGRF-NH2
Lamprey RFa-B GREVNPLWYVGRGVRPIGRF-NH2
FIGURE 1 | Identified or predicted amino acid sequences of PrRP and
PrRP2 in vertebrates. Bold characters indicate conserved amino acid
residues. Identified or predicted PrRP-20 or PrRP2-20 peptide sequences
are underlined.
human PrRP genes are located on chromosomes 9q36 and 2q37.3,
respectively. The genomic organization and promoter function of
the rat PrRP gene have been examined by Yamada et al. (6).
In non-mammalian vertebrates, the structure of the PrRP gene
has not been well investigated. Since non-mammalian vertebrates
have two types of PrRP (namely, PrRP and PrRP2), which is orthol-
ogous to mammalian PrRP was a problem. This problem was
solved by the synteny analysis done by Wang et al. (5). Chicken,
X. tropicalis, and zebrafish PrRP genes are located on chromo-
some 7, scaffold 15, and chromosome 9, respectively. These PrRP
genes are surrounded by several genes such as leucine-rich repeat
interacting protein 1, ras-related protein Rab-17, melanophilin, and
collagen type VI, alpha 3 (5). These neighboring genes (surround-
ing the PrRP gene) are also observed on human chromosome
2q37.3, where the PrRP gene is located. Based on PrRP genes in
non-mammalian vertebrates, the amino acid sequence of their pre-
proPrRPs was predicted and its sequence showed low-to-moderate
homology to mammalian PrRP.
PrRP2
Fujimoto et al. (2) first isolated a novel bioactive peptide from
the Japanese crucian carp. Since the peptide contains an RF-amide
sequence at the C-terminus, it was named Carassius RFamide (C-
RFa). Later, C-RFa homologs were isolated from several teleosts,
such as chum salmon and tilapia, and their amino acid sequences
are identical to the crucian carp (7–9). This amino acid sequence
shows similarity to those of mammalian PrRP-20 (Figure 1).
Together with their stimulation of PRL release in teleosts (10,
11), they have been considered the teleost orthologs of PrRP-20
(12). However, a recent phylogenetic study revealed that they do
not originate from the same gene as mammalian PrRP (5). It is,
therefore, natural that the nomenclature should be reviewed and
it would be better renamed PrRP2 (5). Sea bream and zebrafish
PrRP2-20s predicted from the cDNA also show the identical
sequence [Figure 1; (5, 13, 14)]. Additionally, two putative PrRP2
consisting of 37 or 36 amino acids, like PrRP-31, were predicted
from the analyses of cleavage sites, but such a longer form of PrRP2
has not been identified in teleosts.
PrRP2 was also identified in chicken: both PrRP2-31, which
consists of 31 amino acids and the C-terminal PrRP2-20 are
present in the brain (15). In several non-mammalian vertebrates,
such as Xenopus laevis and X. tropicalis, PrRP2s have been pre-
dicted from cDNA (5, 16). All the PrRP2s are expected to have
RF-amide motifs at the end of their C-terminuses and their
PrRP2-20s show high homology to teleost PrRP2. The amino acid
sequences of teleost PrRP2 and chicken PrRP2-20 are identical
(Figure 1), and the sequence of Xenopus shows high homol-
ogy (Figure 1). In one animal species, the sequence of PrRP2 is
moderately similar to that of the respective PrRP. PrRP-like RF-
amide peptides are also found in sea lamprey, and named RFa-A
and RFa-B (17) (Figure 1). These peptides show relatively high
homology to teleost,Xenopus, and chicken PrRP2 but not to PrRP,
suggesting that they are homologous to PrRP2. RFa-B, in partic-
ular, has an amino acid sequence similar to teleost, Xenopus, and
chicken PrRP2s compared with RFa-A. If lamprey RFa-A and RFa-
B are, respectively, orthologous to PrRP and PrRP2, these peptides
originated at least from the stage of primitive vertebrates.
Chicken and X. laevis preproPrRP2 consist of 108 amino acids
(15, 16). Chicken and X. tropicalis preproPrRP2, respectively, have
low homology with their preproPrRP (5, 15). Their amino acid
sequences suggest the occurrence of a longer form of PrRP2 such
as PrRP2-31 in X. laevis (16) as shown in chickens. The deduced
amino acid sequence of X. laevis PrRP2-31 shows high homology
with chicken PrRP2-31 and moderate homology with mammalian
PrRP-31. Although PrRP2-20 can activate PrRP-R1, PrRP-R2,
and PrRP2-R in chickens (5), N-terminal 11 residue sequence
of PrRP2-31 also seem to be important for activity because cen-
tral injection of PrRP2-20 did not affect feeding behavior and
blood constituents while PrRP2-31 stimulates feeding behavior
and modified blood constituents (15, 18).
In contrast to non-mammalian vertebrates, PrRP2 has not been
identified in mammals. PrRP2 genes are located on chromosome
3, scaffold 359, and chromosome 24 in chicken, X. tropicalis, and
zebrafish, respectively, and genes of myosin VIIA and Rab interact-
ing protein (MYRIP) exist on each chromosome or scaffold (5).
The MYRIP gene is located on human chromosome 3, but the
PrRP2 gene has not been identified. Based on a phylogenetic rela-
tionship among PrRPs and PrRP2s (Figure 2), divergence of PrRP
and PrRP2 from the common ancestral gene occurred faster than
their specialization in each vertebrate. It is, therefore, possible that
PrRP2 might have been lost during mammalian evolution. Lager-
ström et al. (4) could not find PrRP or PrRP2 in any invertebrate
genome, suggesting that these peptides most likely arose during
the tetraploidizations.
RECEPTORS FOR PrRP AND PrRP2
Hinuma et al. (1) first identified the human PrRP receptor (hGR3,
PrRP-R), which is virtually identical to the orphan receptor GPR10
(19). The hGR3 receptor was expected to be a counterpart of the
rat orphan receptor UHR-1 (20), sharing 89% amino acid homol-
ogy. These PrRP-Rs share a slight homology with the neuropeptide
Y (NPY) receptor in amino acid sequences, and a micromolar level
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 Human PrRP
 Chicken PrRP
 Green turtle PrRP
 Western clawed frog PrRP
 Zebrafish PrRP
 Chicken PrRP2
 American alligator PrRP2
 Western clawed frog PrRP2
 Zebrafish PrRP2
 Lamprey RFa-B
FIGURE 2 | Phylogenetic relationship between proPrRP and proPrRP2 in vertebrates. The tree was constructed using the maximum likelihood method,
plotted in MEGA6.
of NPY was able to bind and inhibit completely the PrRP-induced
response in cells, which express PrRP-R, suggesting that PrRP-R
shares a common ancestor with NPY receptors (13). On the other
hand, it is likely that PrRP binds to not only the PrRP receptor but
also other receptors such as neuropeptide FF receptor-2 (21).
In non-mammalian vertebrates, Lagerström et al. (13)
first identified PrRP-R. They found three PrRP-Rs (PRLHR1,
PRLHR1B, and PRLHR2) in chicken, two receptors (PRLHR1 and
PRLHR2) in pufferfish, and one receptor (PRLHR2) in zebrafish.
Thereafter, Wang et al. (5) suggested that PRLHR1 and PRLHR1B
are receptors for both PrRP and PrRP2 in chicken while PRLHR2
is a specific receptor for PrRP2 in chicken. Based on these features,
the names were changed from PRLHR1 and PRLHR1B to PrRPR1
and PrRPR2, respectively, and from PRLHR2 to C-RFaR (5). As
noted above, we suggest that C-RFa be renamed PrRP2, so C-RFa-
R should be renamed PrRP2-R. In this review, we use the PrRP
receptor terms PrRP-R1, PrRP-R2, and PrRP2-R for chicken and
other non-mammalian vertebrates.
PrRP-R
Mammalian PrRP-R belongs to the 7-transmembrane recep-
tor (7TMR) superfamily. Radioiodinated PrRP-20 and -31 bind
equally and with high affinity to these orphan 7TMRs expressed
in CHO cells and HEK293 cells (1, 22, 23). Except for non-
mammalian PrRP2, none of the known native ligands including
RF-amide neuropeptide FF demonstrate any affinity for GPR10
(23). These studies indicate that PrRPs are specific, high affinity
ligands for PrRP-R. In rats, Satoh et al. (24) suggested that there
may be different subtypes of PrRP-R, which may be different from
UHR-1.
The human PrRP-R gene is located on chromosome 10q26.13
and consists of two exons and one intron (25), although the entire
coding region is intronless. In GH3 pituitary tumor cells or pri-
mary cultures of anterior pituitary cells from rat, the PrRP receptor
appears to signal via multiple kinase pathways including mitogen-
activated protein kinase (MAPK), Jun N-terminal kinase (JNK),
and serine/threonine kinase (Akt/protein kinase B) to the PRL pro-
moter; these pathways require an Ets transcription factor (26, 27).
Since the Akt pathway is associated with cell survival and growth,
PrRP may function not only to control PRL expression, but also
to maintain PRL cell number (28).
In non-mammalian vertebrates, two subtypes of the PrRP
receptor, PrRP-R1 and PrRP-R2, have been predicted (5, 13).
In X. tropicalis and chicken, the amino acid sequences of PrRP-
R1 and PrRP-R2 are moderately conserved and show moderate
homology with mammalian PrRP-R. The PrRP-R1 and PrRP-R2
genes are located on scaffold 605 and 40, and on chromosome
6 and 22 in chickens (5), respectively. Their surrounding genes
are well conserved between human beings, chickens, and Xeno-
pus. Based on a synteny analysis, PrRP-R1 but not PrRP-R2 is
thought to be orthologous to mammalian PrRP-R [Figure 3; (13)].
Although the PrRP-R2 gene is expected to exist on chromosome
8 in human beings based on the surrounding genes, it has not yet
been identified. Like mammalian PrRP-R, the entire coding region
of cPrRPR1 is intronless while the coding region of cPrRPR2 is
interrupted by an intron (5, 13). In chickens, both PrRP and PrRP2
show affinity to PrRP-R1 and PrRP-R2 to a similar extent (5).
Both receptors possess conserved structural motifs, which are also
well conserved within the rhodopsin family of G-protein coupled
receptors. In chickens, PrRP-R1 and PrRP-R2 appear to be func-
tionally coupled with the intracellular protein kinase A signaling
pathway (5). The activation of these receptors is also expected to
trigger Ca2+ release from intracellular stores (5).
Teleost PrRP-Rs are also predicted from their genome. For
example, Watanabe and Kaneko (29) characterized PrRP-R of
tilapia. This receptor may be categorized as PrRP-R2 because its
amino acid sequence shows higher homology to X. tropicalis and
chicken PrRP-R2 rather than other receptors.
PrRP2-R
PrRP2-Rs have been identified in several non-mammalian verte-
brates, such as zebrafish,X. tropicalis, and chickens (5, 13). Among
these animals, the structures ofXenopus and chicken PrRP2-R have
been well studied. The entire coding region of the chicken PrRP2-
R gene is intronless (5), while X. tropicalis PrRP2-R consists of
two exons and one intron as does mammalian PrRP-R. Xenopus
and chicken PrRP2-R, respectively, consists of 364 and 361 amino
acids, and show moderate homology between them. In contrast,
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Human PrRP-R
Rat PrRP-R
Chicken PrRP-R1
Western clawed frog PrRP-R1
Chicken PrRP-R2
Western clawed frog PrRP-R2
Chicken PrRP2-R
Western clawed frog PrRP2-R
FIGURE 3 | Phylogenetic relationship between PrRP-R, PrRP-R1, PrRP-R2, and PrRP2-R in vertebrates. The tree was constructed using the maximum
likelihood method, plotted in MEGA6.
Xenopus and chicken PrRP2-R also show lower homology to their
PrRP-R1 and PrRP-R2, respectively.
Like PrRP-Rs, PrRP2-R belongs to the neuropeptide recep-
tor family of the 7TMR superfamily. In chickens, stimulation of
PrRP2-R also activates the intracellular protein kinase A signal-
ing pathway. Chicken PrRP2-R is activated by both PrRP and
PrRP2 in vitro, but PrRP2 is 150 times more potent than PrRP
(5). On the other hand, chicken PrRP-Rs are similarly activated
by PrRP and PrRP2. Therefore, PrRP2-R is a specific receptor for
PrRP2 in chickens. This idea was supported by studies using teleost
showing that Japanese crucian carp PrRP2 can also interact with
human PrRP-R (30). In addition, teleost PrRP2, not mammalian
PrRP, stimulates PRL release from tilapia pituitary, suggesting that
PrRP2-R might be related to PRL secretion and mammalian PrRP
would not be able to bind to teleost PrRP2-R (8).
Chicken, X. tropicalis, and zebrafish PrRP2-R genes are located
on chromosome 5, scaffold 627, and chromosome 17, respectively
(5). Genes surrounding the PrRP2-R gene are well conserved
between vertebrates including mammals. The human PrRP2-R
gene is expected to exist on chromosome 15, but it has not yet
been identified as well as PrRP2 gene (5). Phylogenetic study
implies that the PrRP2 and PrRP-R2 genes disappeared through
the evolution of mammals.
DISTRIBUTION OF PrRP, PrRP2, AND THEIR RECEPTORS
PrRP AND PrRP-R
Prolactin-releasing peptide is widely distributed in central and
peripheral organs in mammals (Table 1). In the rat brain, PrRP
nerve cell bodies are distributed in the hypothalamic dorsome-
dial nucleus (DMN), the nucleus of the solitary tract (NTS), and
ventral and lateral reticular nuclei (VLRN) in the medulla oblon-
gata (31–33). PrRP neurons in the VLRN and NTS are considered
to be A1 and A2 noradrenergic neurons, respectively (34, 35).
PrRP nerve fibers project to several brain regions, such as the
bed nucleus of the stria terminalis, hypothalamic paraventricular
nucleus (PVN), hypothalamic periventricular nucleus (PerVN),
and basolateral amygdaloid complex (31, 36). PrRP nerve fibers in
the hypothalamus appear to contact catecholaminergic, oxytocin,
corticotrophin-releasing hormone (CRH), and somatostatin neu-
rons (36–39). On the other hand, PrRP neurons do not project
to the external lamina of the median eminence (33, 40), where
hypophysiotropic factors of hypothalamic origin gain access to the
Table 1 | Comparison of the distribution of PrRP and PrRP2 mRNA
among mammals, avians, and teleosts.
Mammala Avianb Teleost
PrRP PrRP PrRP2 PrRP2
Whole brain + + + +c
Telencephalon – + + –d, +e
Diencephalon + + + +d,e
Midbrain – + + +d,e
Cerebellum – + + –d
Hindbrain + + + +d,e
Spinal cord + – – +d
Pituitary – + + +c,d, –e
Thyroid gland +
Heart – – + –d
Lung + + +
Liver – – + +c
Spleen – – – –c
Pancreas + – +
Kidney + – + –c,d
Gut + – + +c,d
Adipose tissue –
Skeletal muscle – + + –c
Testis + + +
Ovary – + + +c
aRat (41).
bChicken (5).
cMudskipper (12).
dSea bream (14).
eGoldfish (45).
+: Definite expression; –: little or nothing.
Blank columns indicate “not examined.”
Distribution of PrRP has not yet been investigated in teleost.
In rats, PrRP mRNA expression is also observed in thymus, trachea, submandibu-
lar gland, adrenal gland, and uterus (see PrRP and PrRP-R).
hypophysial portal vasculature and the anterior lobe. An axonal
transport study (35) also revealed that the hypothalamic PrRP
neurons are not directly connected to the anterior pituitary. The
distribution of PrRP in the brain was also investigated in human
beings and sheep, and their distributions are basically similar to
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those of rats (41–43). PrRP and its mRNA have also been found
in a number of peripheral tissues, including the pituitary gland,
adrenal gland, lung, pancreas, and testis (41, 44) (Table 1).
As with PrRP itself, PrRP-R-expressing neurons are widely dis-
tributed throughout the brain, including the PVN, hypothalamic
preoptic area (POA), PerVN, ventrolateral hypothalamus, DMN,
reticular thalamus, and area postrema (22, 33, 38). In contrast
to the central nervous system, the distribution of PrRP-R seems
to be sparse in the peripheral tissues. PrRP receptor mRNA has
been found in the pituitary gland, adrenal gland, stomach, and
femur (41).
In contrast to mammals, the distribution of PrRP in non-
mammalian vertebrates has not been well investigated. Wang et al.
(5) found that PrRP mRNA is expressed in both central and
peripheral tissues in chickens. In the central nervous system, PrRP
mRNA is present in various brain regions including the hypothal-
amus, but not in the spinal cord (Table 1). In the peripheral tissues,
PrRP mRNA is present in the pituitary, muscle, lung, testis, and
ovary. These distributions in chickens are almost similar to those
of mammals.
In chickens, PrRP-R1 and PrRP-R2 mRNA are widely and sim-
ilarly distributed throughout the brain as they are in mammals
(5). On the other hand, their distribution in the peripheral tis-
sues is different (5). PrRP-R1 mRNA is present in the pituitary,
heart, small intestine, kidney, liver, lung, muscle, testis, ovary, and
spleen. PrRP-R2 mRNA is distributed in similar tissues to PrRP-
R1, but it is not present in the pituitary, liver, and spleen. The
difference in distribution indicates that they are functionally dif-
ferentiated in chickens. In tilapia, PrRP-R (probably PrRP-R2)
mRNA is expressed in the brain, pituitary, heart, spleen, kidney,
and rectum but not liver (29). The mRNA expressions of PrRP-R
in the peripheral tissues are different between vertebrates, sug-
gesting that the action of PrRP is different between chickens and
mammals.
PrRP2 AND PrRP2-R
PrRP2 mRNA is distributed in the central nervous system in non-
mammalian vertebrates (5, 12, 14, 45, 46) (Table 1). Further, a
histological survey has been performed only in teleosts using the
antisera against teleost PrRP2 whose cross-reactions with PrRP
are unclear. Based on these studies, PrRP and/or PrRP2 perikarya
and nerve fibers are thought to be distributed in the hypothala-
mus and pituitary of teleosts (7, 47). Further studies using specific
antiserum for PrRP2 will clarify the actual distribution of PrRP2
in the brain of teleosts.
PrRP2 mRNA is abundantly expressed not only in the brain
but also in the peripheral organs of teleosts (Table 1). In mud-
skippers, PrRP2 mRNA is expressed in the liver, gut, and ovary,
while significant levels of expression were also detected in the skin
and kidney (48). Within the cyprinid retina, PrRP2 mRNA is also
abundantly expressed (46). Corresponding to the distribution of
PrRP2 mRNA in the mudskipper, relatively high expression of
extrapituitary PRL was observed in the liver, gut, and ovary (48).
PrRP2 may stimulate PRL expression in an autocrine/paracrine
manner as observed in human decidua PrRP-PRL (49).
In chickens, PrRP2 mRNA and mature peptides (PrRP2-20
and PrRP2-31) are expressed in the telencephalon, midbrain,
cerebellum, hindbrain, and hypothalamus of the brain (5, 15).
Messenger RNA is also expressed in the peripheral organs such as
the heart, small intestine, kidney, liver, lung, muscle, ovary, testis,
pituitary, and pancreas (5). PrRP2-R mRNA is also observed in
similar tissues to PrRP2, but it is not expressed in the heart and
pancreas.
BIOLOGICAL ACTIONS OF PrRP AND PrRP2
In vertebrates, it has been reported that both PrRP and PrRP2
are related to many physiological roles such as the regulation
of pituitary hormone release, feeding/energy metabolism, stress
response, cardiovascular regulation (50), retinal information pro-
cessing (51), regulation of sleep (52), and stimulation of visceral
muscle contraction (2) (Table 2). Brain PrRP is also thought to
Table 2 | Comparison of representative actions of PrRP and PrRP2
between mammals, avians, and teleosts.
Action Mammal Aviana Teleost
PrRP PrRP PrRP2 PrRP2
PRL release
In vitro ↑b,c, →b,c ↑d,e
In vivo
Peripheral injection ↑b, →f,g ↑ ↑d,e
Central injection ↑b,f, →g ↓ ↓
GH release
In vitro ↑c ↓e, →d
In vivo
Peripheral injection ↓ ↓d, →e
Central injection ↓b ↓
Activation of HPA axis
Peripheral injection →e,h
Central injection ↑b,f, →g ↑ →
Food intake
Peripheral injection → → ↓h
Central injection ↓b,i, →f ↑ ↑
aChicken (15, 18, 57).
bRat (1, 3, 37, 38, 52, 58, 67).
cHuman being (59).
dRainbow trout (7).
eTilapia [PRL-releasing effect induced by peripheral injection was observed only in
females and suppression of GH release in vitro was observed only in males, (8)].
fCattle (60, 61).
gSheep (43, 62).
hGoldfish (11, 45).
iMouse (63).
↑: Increase; ↓: Decrease; →: No change.
Blank columns indicate “not examined.”
Actions of PrRP have not yet been investigated in teleost.
In rats, PrRP is related to the releases of oxytocin, vasopressin, FSH, and LH,
and the regulation of stress response, sleeping, blood pressure, and so on (see
Biological Actions of PrRP and PrRP2).
In Japanese crucian carp, PrRP alters somatolactin secretion and contracts the
intestine (see Discovery of Prolactin-Releasing Peptides and Biological Actions of
PrRP and PrRP2).
www.frontiersin.org November 2014 | Volume 5 | Article 170 | 5
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tachibana and Sakamoto Prolactin-releasing peptides in vertebrates
be related to the regulation of reproduction because brain PrRP
mRNA expression increases during proestrus of the gonadal cycle
and mid-period of pregnancy (53). In Xenopus, PrRP2 might
be related to the regulation of metamorphosis because PrRP2
mRNA expression peaks at premetamorphosis (16). These func-
tions have been well summarized in several reviews [for example,
see Ref. (12, 54–56)]. Among them, the regulations of pituitary
hormone release, feeding behavior, and stress have been well stud-
ied in both PrRP and PrRP2. In this section, we describe the
current knowledge of the actions of PrRP and PrRP2 in PRL
release, hypothalamus–pituitary axes, feeding/energy metabolism,
and stress.
EFFECT ON PRL SECRETION
PrRP
Hinuma et al. (1) first found that PrRP stimulates PRL release
from the rat pituitary adenoma-derived cell line and from primary
cultures of anterior pituitary cells harvested from lactating female
rats, the most sensitive model of PRL-releasing factor activity (64).
This PRL-releasing activity appeared to be specific since PrRP
did not affect the release of other anterior pituitary hormones
such as luteinizing hormone (LH), follicle-stimulating hormone
(FSH), thyroid-stimulating hormone, growth hormone (GH), and
adrenocorticotropic hormone (ACTH). However, further studies
revealed that the effect of PrRP on PRL secretion was inconsistent.
For example, PrRP stimulated PRL release only when a higher dose
was applied (65, 66) or had no effect (3). In vivo, intravenous (IV)
injection of PrRP-31 induces PRL release dependent on the estrus
cycle and estrogen in rats (67, 68). On the other hand, IV injection
of PrRP has no effect on PRL secretion in cattle (69), while intrac-
erebroventricular (ICV) injection of PrRP temporarily increases
PRL secretion (60). In addition to this, neither IV nor ICV injec-
tions induce PRL secretion in female sheep (43), suggesting that
PrRP is not important in stimulating PRL secretion in ruminants.
As noted above, PrRP neuronal terminals are not observed in
the external layer of the median eminence, suggesting that PrRP
is expected to stimulate PRL release with different mechanism(s)
from ordinary hypophysiotropic hormones. The small number
of PrRP nerve fibers in the posterior pituitary (36) suggests that
PrRP in the posterior pituitary might be transported to the ante-
rior pituitary through a short hypophyseal portal system. PrRP-R
expressed not only in the anterior pituitary but also in the ros-
tral and medio-basal hypothalamus and in the hypothalamic PVN
suggests possible indirect pathways, which modulate PRL release,
but the effects of PrRP on PRL release are not consistent among
studies in rats (3, 52, 70–73). In the hypothalamic explants, PrRP-
31 increases the release of vasoactive intestinal peptide (VIP) and
galanin, which are known to stimulate PRL release (70). ICV injec-
tion of PrRP stimulates activity of tuberoinfundibular dopamin-
ergic neurons, which are involved in regulation of PRL secretion
(39). It is, therefore, possible that PrRP modifies the activity of
dopaminergic, VIP, and galanin neurons in the hypothalamus and
then stimulates PRL release. In human beings, PrRP and PrRP-
R are expressed in the uterine decidua and PrRP increases PRL
release from the primary cultures of decidual stromal cells in vitro
(49), suggesting that PrRP is also a local modulator of decidual
PRL release.
The effect of PrRP on PRL release is controversial in mam-
mals, and such a role has not yet been well investigated in non-
mammalian vertebrates. Incubation of the tilapia pituitary with
mammalian PrRP had no effect on the release of two PRL iso-
forms, PRL177 or PRL188, although PrRP2 stimulated the release.
Interestingly, ICV injection of mammalian PrRP decreases plasma
PRL level in chicks (18). Further studies using homologous systems
of fish, amphibians, reptiles, and birds are needed.
PrRP2
In contrast to PrRP, PrRP2 is recognized as a strong candidate for
the specific stimulator of PRL secretion in teleosts. For example,
PrRP2 stimulates PRL release from primary cultures of rain-
bow trout pituitaries (7). In tilapia, PrRP2 also stimulates PRL
release in vitro from the rostral pars distalis of the pituitary (8)
equipotently with GnRH, another candidate PRL-releasing fac-
tor. The PRL-releasing effect of PrRP2 is also observed in vivo:
plasma PRL concentration increases with intra-arterial (10) and
intraperitoneal (IP) injection of PrRP2 (7). In tilapia, injection
of PrRP2 elevates plasma PRL levels only in females but not in
males (8), in accordance with the gender-biased effects in rats.
Additionally, intra-arterial injection of PrRP2 increases the PRL
mRNA level in the pituitary of trout in vivo (10, 48). More-
over, PrRP2 antiserum decreases mRNA expression of PRL in
goldfish, suggesting that endogenous PrRP2 is essential for PRL
expression (11).
PrRP2 is thought to be involved in adapting to new osmotic
conditions in euryhaline teleosts. This idea is also supported by
PRL having an important role in osmotic regulation in teleosts.
PRL mRNA expression in the pituitary increases during adapta-
tion to low osmotic conditions. Similarly, PrRP2 mRNA expres-
sion increases under freshwater and terrestrial conditions in the
brain of euryhaline mudskippers and under ion-poor fresh-
water in the hypothalamus of goldfish (45). As brain PrRP2,
pituitary and gut PrRP2 are also related to acclimation to low
osmotic conditions because PrRP2 mRNA in the pituitary and
gut increases when euryhaline silver sea bream and mudskipper,
respectively, adapt to low salinities (14, 74, 75). These data sug-
gest that PRL expression is regulated by not only brain PrRP
but also peripheral PrRP2 in teleosts. In fact, the changes in
PRL mRNA in the gut parallel those in PrRP2 mRNA in the gut
of mudskipper (74). In addition, the changes in PrRP2 mRNA
in the hypothalamus do not parallel that of PRL mRNA in
the pituitary (14, 75). These PrRP2 mRNA expressions during
osmotic acclimation might be regulated by the olfactory system
because removing the olfactory rosette lowers the increase in
PrRP2 mRNA expression under hypo-osmotic conditions in sea
bream (75).
On the other hand, from bullfrog pituitary cells, PrRP2-20
and PrRP2-31 increased PRL release (to 130–160% of control)
in vitro, but their effects were much less potent than thyrotropin-
releasing hormone-induced PRL release (16). In chicks, similarly,
IP injection of PrRP2-31 increased plasma PRL concentration,
but the effect was not marked [to 140% of control, (15)]. In con-
trast, ICV injection of PrRP2-31 decreases plasma PRL level in
chicks (15), but the mechanism of this inhibition of PRL release is
unclear.
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EFFECT ON HYPOTHALAMUS–PITUITARY AXES
CRH–ACTH axis
In the rat brain, PrRP is produced in some A1/A2 noradrenergic
neurons in the medulla oblongata, which mediate stress signals
in the central nervous system (76–80). In addition, it has been
demonstrated that PrRP neurons innervate the CRH neurons by
synaptic connection in rats (37). Stress information sent by A1/A2
noradrenergic neurons activates the hypothalamic CRH neurons,
and then stimulates ACTH release from the anterior pituitary (81–
83), suggesting that PrRP stimulates ACTH secretion via activating
CRH neurons in rodents. Indeed, ICV injection of PrRP increases
c-Fos expression in the CRH neurons and plasma ACTH level
while systemic injection had no effect (37, 84). Additionally, PrRP-
induced ACTH release is blocked by peripheral pretreatment with
the CRH antagonist, alpha-helical CRH (37), demonstrating that
PrRP activates the CRH neurons for the hypothalamic–pituitary–
adrenal (HPA) axis in the stress response. A similar effect of PrRP
was also observed in castrated bulls because ICV injection of PrRP
increases cortisol secretion (60). In sheep, on the other hand, ICV
injection of PrRP does not alter cortisol secretion (62), suggesting
that the effect of PrRP is different between animal species. It has
been reported that vasopressin rather than CRH might be a major
secretagogue of ACTH in sheep, which is different from rats and
pigs (85–87). Therefore, the difference in the hypothalamic reg-
ulation of the HPA axis might contribute to the unique effect of
PrRP in sheep (60).
Intracerebroventricular injection of mammalian PrRP increases
the plasma corticosterone level in chicks (18), suggesting that brain
PrRP-induced activation of the HPA axis is conserved. On the
other hand, the plasma corticosterone level is not changed by ICV
injection of PrRP2-20 in chicks (18). In addition, plasma cortisol
levels are not increased by IP injection of PrRP2 in tilapia and gold-
fish (8, 11). These results suggest that PrRP2 might not activate the
HPA axis in chicks and teleosts.
Somatostatin–GH axis
In rats, somatostatin neurons in the hypothalamic PerVN are con-
tacted by PrRP nerve terminals and express the PrRP receptor.
These facts suggest that PrRP alters the activity of somatostatin
neurons. Indeed, ICV injection of PrRP-31 induces expression of
the immediate early gene (NGFI-A) in these somatostatin neu-
rons in rats (38). The injection of PrRP-31 decreases the plasma
GH level (38, 52), and the effect is abolished by depletion or neu-
tralization of somatostatin in rats (38). Therefore, PrRP directly
activates somatostatin neurons to stimulate somatostatin release
and then inhibits GH release from the anterior pituitary in rodents.
Although the relationship between PrRP and somatostatin has
not been well investigated in non-mammalian vertebrates, ICV
injection of mammalian PrRP was reported to reduce the plasma
GH level in chicks (18), suggesting that their relationship is con-
served in other vertebrates. The decrease in GH level was also
observed in chicks after PrRP2-31 was centrally injected (15).
IP injection of PrRP2 also decreases the GH level in rainbow
trout (7). It is, therefore, possible that PrRP2 is also related to
the somatostatin–GH axis in non-mammalian vertebrates. PrRP2
does not affect GH secretion in cultured pituitaries of rainbow
trout in vitro (7), implying that the inhibitory effect of PrRP2
may also be mediated by the release of somatostatin. Thus, it is
likely that the inhibitory effect on GH release is well conserved in
vertebrates and between PrRP and PrRP2.
Other
In mammals, PrRP is thought to regulate oxytocin release because
PrRP neurons have synaptic contact with oxytocin neurons in the
PVN (36) and PrRP receptors are present in the oxytocin neurons
in rats (33). Indeed, central injection of PrRP (10 nmol/300 g rat)
elevates the plasma oxytocin level in conscious rats (88). Yamashita
et al. (89) also indicated that oxytocin neurons in the hypothala-
mus and bed nucleus of the stria terminalis show immunoreactiv-
ity of PrRP receptors, and that application of PrRP to isolated
supraoptic nuclei facilitates the release of oxytocin. They also
demonstrated that vasopressin neurons in the hypothalamus show
immunoreactivity of PrRP receptors and that PrRP stimulates
vasopressin release from the supraoptic nuclei in rats. Similarly,
central injection of PrRP also increases the plasma vasopressin
level in rats, although the effect is observed only in females (88).
PrRP stimulates release of LH and FSH via a hypothalamic mech-
anism, such as VIP and galanin in rats (70). PrRP is also related to
the ovarian steroid-induced LH surge because it is reduced by ICV
injection of PrRP antiserum (90). PrRP gene expression is directly
regulated by gonadal steroid hormones because PrRP neurons in
the medulla oblongata are co-localized with receptors for estrogen
or progesterone (53). In addition, administering estrogen or prog-
esterone to ovariectomized rats induces PrRP mRNA expression
in the medulla oblongata, as well as release of PrRP in the medial
POA (53, 68, 91).
PrRP2 decreases plasma somatolactin levels in rainbow trout at
30 min after intra-arterial injection of PrRP2 (48). On the other
hand, Moriyama et al. (7) demonstrated that PrRP2 increases the
plasma somatolactin level at 9 h after IP injection, and stimu-
lates somatolactin release only by pharmacological doses of PrRP
in vitro. The effect of PrRP on somatolactin release might be
mediated by an indirect endocrine mechanism as suggested by
Moriyama et al. (7), although the distribution of PrRP neuronal
terminals are also located near somatolactin cells in the trout
pituitary.
REGULATION OF FOOD INTAKE AND ENERGY HOMEOSTASIS
Central injection of PrRP, especially into the DMN, reduces food
intake in rats without inducing conditioned taste aversion (58, 92–
94). The anorexigenic effect is also observed in mice (63). In addi-
tion, PrRP mRNA expression decreases with fasting during states
of negative energy balance, like other anorexigens, in rats (58).
Furthermore, immuno-neutralization of endogenous PrRP using
monoclonal antibody has been demonstrated to induce hyper-
phagia in mice (95). Moreover, hyperphagia is also observed in
PrRP-deficient mice (95) and PrRP-R-deficient mice (100). These
results show that endogenous PrRP is one of the anorexigenic
peptides in mammals. Takayanagi et al. (95) also reveal that PrRP
regulates meal size rather than meal frequency in mice. It has been
demonstrated that meal size is regulated by several satiety signals
including cholecystokin (CCK). CCK is released from the intestine
and then activates afferent vagal nerves that project to the medulla
oblongata. CCK is also thought to activate PrRP neurons because
injection of CCK induces c-Fos expression in PrRP-containing
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neurons distributed in the NTS (93). In addition, the anorexi-
genic effect of CCK disappears in both PrRP-deficient mice (95)
and PrRP-R-deficient mice (63). Thus, PrRP also appears to medi-
ate the anorexigenic effect of CCK. Leptin is also considered an
upstream regulator of the anorexigenic effect of PrRP because the
leptin receptor is expressed in PrRP neurons in the brainstem and
hypothalamus (94, 96). In addition, PrRP mRNA expression is low
in Zucker rats, which are obese due to the lack of a leptin receptor
(94). Furthermore, leptin induces the expression of the phospho-
rylated signal transducer and activator of transcriptional protein
3 in PrRP neurons (95). Moreover, leptin-induced anorexia is not
observed in PrRP-deficient mice. Therefore, PrRP also mediates
the anorexigenic signal of leptin (95).
The downstream mechanisms underlying the anorexigenic
effect of PrRP remain to be clarified. Seal et al. (92) suggested
that the anorexigenic effect of PrRP is also mediated by alpha-
melanocyte-stimulating hormone (MSH) and neurotensin, both
of which are well-known anorexigenic peptides. CRH and oxy-
tocin are also thought to be related to the anorexigenic mechanism
of PrRP. As noted above, central injection of PrRP activates CRH or
oxytocin neurons in the hypothalamus, and the anorexigenic effect
of PrRP is attenuated by a CRH receptor antagonist or oxytocin
receptor antagonist (63, 97), showing that they mediate PrRP-
induced anorexia. Furthermore, an oxytocin receptor antagonist
attenuates the anorexigenic effect of CCK (98, 99). Re-feeding and
CCK-induced Fos expression in several brain regions including the
PVN was impaired in PrRP-deficient mice. CCK-induced oxytocin
release was also impaired in PrRP-deficient mice. Collectively, it
is expected that the CCK-PrRP-oxytocin system is an important
anorexigenic pathway of PrRP.
Endogenous PrRP is also related to energy metabolism in
mammals because PrRP-deficient or PrRP-R-deficient mice show
late-onset obesity (95, 100–102). Furthermore, the Otsuka Long-
Evans Tokushima Fatty (OLETF) rat strain, which exhibits obesity
and diabetes, has a mutated GPR10 gene (103). Streptozotocin-
induced diabetic rats also show lower mRNA expression of PrRP
and it is reversed by insulin (96). In rats, ICV injection of
PrRP increases body temperature and oxygen consumption, also
suggesting that brain PrRP is related to the control of energy
metabolism (58, 97). In addition to obesity, PrRP-deficient mice
show increased food intake, body fat mass, glucose tolerance, and
increased levels of blood insulin, leptin, cholesterol, and triacyl-
glycerol (95, 100, 102). Similar changes were also observed in PrRP-
R-deficient mice (100, 101). However, PrRP-deficient mice do not
show any change in body temperature, oxygen consumption, or
locomotion activity (95). PrRP-R-deficient male mice also show no
difference in oxygen consumption while consumption is slightly
low in PrRP-R-deficient females (101). The PrRP-R-deficient mice
become obese but the extent is pronounced in females (101). Thus,
it is likely that the role of PrRP in energy metabolism is different
between the sexes. The difference is explained by estrogen because
PrRP-containing neurons in the brainstem express the estrogen
receptor (53). Obesity observed in PrRP-deficient mice is thought
to be related to hyperphagia because pair-feeding abolishes the
induction of obesity in PrRP-deficient mice (95).
PrRP2 is also recognized as an anorexigenic peptide in teleosts
because ICV injection of PrRP2 significantly inhibits feeding
behavior in goldfish (45). In mudskipper, a euryhaline fish, brain
PrRP2 mRNA expression is induced when they are kept in fresh
water (48) where their food intake decreases compared with rear-
ing in sea water (our unpublished observation). Indeed, several
euryhaline fish grow slower in fresh water than in seawater (104),
suggesting the involvement of brain PrRP2.
In contrast to rodents and teleosts, PrRP shows a unique effect
on feeding behavior in steers and chicks. In steers, ICV injec-
tion of PrRP has no effect on food intake (61). Furthermore,
ICV injection of mammalian PrRP increases food intake in chicks
(57). The orexigenic effect is also observed when chicken PrRP
is ICV injected (our unpublished data). Similarly, ICV injection
of PrRP2-31 also stimulates feeding behavior in chicks, although
PrRP2-20 has no effect (15). Thus, the effects of both PrRP and
PrRP2 on feeding behavior are completely opposite to those in
rodents and teleosts, and seem to have changed during the process
of evolution. The reason why PrRP and PrRP2 stimulate feeding
behavior in chicks has not yet been well clarified. Interestingly,
ICV injection of leptin (105) has no effect on feeding behavior in
chicks (105), although CCK, CRH, MSH, and mesotocin (avian
homolog of oxytocin) have an anorexigenic effect in chicks (106–
109) as well as rodents. The difference in the feeding inhibitory
mechanism may contribute to the reason why PrRP does not
suppress feeding behavior in chicks. It is possible that NPY, an
orexigenic factor, is related to the orexigenic effect of PrRP because
ICV injection of PrRP2-31 significantly increases the NPY mRNA
level in the diencephalon in chicks (110). As well as in feeding
regulation, PrRP2 might also be related to energy metabolism in
non-mammalian vertebrates because ICV injection of PrRP2-31
decreases blood insulin, glucose, and non-esterified fatty acid in
chicks (110).
STRESS RESPONSE
As noted in Section “CRH–ACTH Axis,” PrRP neurons project
directly to CRH neurons and oxytocin neurons in the hypothala-
mus (33), and ICV injection of PrRP increases ACTH (84) and
oxytocin release in rats (88). These facts suggest that PrRP is
a mediator of the HPA axis for stress response. In fact, water
immersion-restraint stress dramatically induces c-Fos expression
in the A1/A2 neurons containing PrRP (84). Other stress stim-
uli, such as restraint, conditioned fear, foot shocks, hemorrhage,
exercise, and inflammatory stress, also activate PrRP neurons in
the medulla oblongata and/or DMN (111–114). Additionally, Seal
et al. (92) found that ICV injection of PrRP-31 increases groom-
ing associated with stress response. Immuno-neutralization of
PrRP decreases the activation of the neurons in the hypothalamic
PVN after noxious stimuli (113) or oxytocin release in response
to conditioned fear (111). In addition, contextual conditioned
fear-induced oxytocin and ACTH releases are impaired in PrRP-
deficient mice (115). It is, therefore, likely that brain PrRP has a
facilitative role in stress responses.
In contrast, the injection of PrRP antibodies facilitates ACTH
release in response to exercise, suggesting that PrRP inhibits ACTH
release in response to exercise (116). Restraint stress-induced cor-
ticosterone release is enhanced in PrRP-deficient mice (102). These
data suggest that PrRP also inhibits neuroendocrine responses
to stress. Additionally, contextual conditioned fear-induced
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neuroendocrine responses disappear in PrRP-deficient mice while
the freezing behavior is augmented (115). The mechanisms
underlying these contradictions have not been clarified to date.
Takayanagi and Onaka (55) suggest that the role of PrRP in
stress responses may depend on the nature of the stressful stim-
uli used. Thus, PrRP is involved in integration in the control
of stress responses, whereas the underlying detailed mechanisms
need further investigation.
Intracerebroventricular injection of mammalian PrRP signifi-
cantly increases the plasma corticosterone level in chicks, implying
that brain PrRP is also related to stress response (18). On the other
hand, ICV injection of chicken PrRP2-20 has no effect on the
plasma corticosterone level, suggesting that PrRP2 might not be
involved in stress (18). It is also reported that IP injection of PrRP2
does not alter the plasma cortisol level in tilapia (8). It is, therefore,
possible that PrRP2 is not related to activating the HPA axis and
stress in non-mammalian vertebrates.
CONCLUDING REMARKS
Prolactin-releasing peptide was originally identified as a stimula-
tor of PRL release in mammals. Although further work revealed
that PrRP had less effect on PRL release, PrRP has been shown to
be involved in many physiological actions, such as reproduction,
endocrine functions, feeding behavior and metabolism, and stress
response in mammals, and possibly in other vertebrates (Table 2).
This PrRP may be the less appropriate nomenclature, at least for
mammals. At the same time, as the discovery of PrRP, PrRP2,
whose amino acid sequence is similar to PrRP, was identified from
Japanese crucian carp. PrRP and PrRP2 are thought to have orig-
inated from a common ancestral gene by the second round of
whole genome duplication. In contrast to PrRP, PrRP2 is thought
to exist only in non-mammalian vertebrates, and to be essential
for PRL secretion in teleosts and important for non-mammalian
vertebrates. The physiological actions of PrRP and PrRP2 seem
to overlap in non-mammalian vertebrates (Table 2), and may
have converged into those of PrRP in mammals. Consequently, the
PrRP2 gene might have diminished in mammals during evolution.
The origin of PrRP and PRL might provide a key to knowing
how PrRP acquired its diverse functions in vertebrates. Moriyama
et al. (17) found two RF-amide peptides (RFa-A and RFa-B),
homologous to PrRP, from sea lamprey. The amino acid sequence
is similar to PrRP2 rather than PrRP (Figures 1 and 2), especially
in RFa-B. If lamprey RFa-A and RFa-B are, respectively, ortholo-
gous to PrRP and PrRP2, these peptides originated at least from
the stage of primitive vertebrates. Interestingly, lamprey is thought
not to possess PRL (117), suggesting that PrRP is generated prior
to the occurrence of PRL. Especially in teleosts, PRL is widely
expressed in extrapituitary organs, and PrRP2 and its receptor
system might concomitantly obtain to regulate these PRL expres-
sions. Conversely, the lack of this extrapituitary PRL might be
associated with the fact that the PrRP2-PrRP2 receptor system was
not necessary for regulating PRL and disappeared in mammals.
On the other hand, the effect of PrRP on GH secretion is com-
monly observed among vertebrates. Moriyama et al. (17) found
that both RFa-A and RFa-B decrease GH mRNA expression in vitro
in lamprey. As noted above, PrRP or PrRP2 inhibits GH release
from the pituitary in mammals, chicks, and teleosts, suggesting
that the roles of PrRP and PrRP2, at least the suppression of GH
release, occur with the appearance of primitive vertebrates. Since
PRL is a member of the GH family and originated from a common
ancestor, the diversity of the physiological roles of PRL and PrRP
are thought to have developed with the evolution of GH rather
than PRL.
The conserved effect of PrRP on feeding behavior may also
be generated in ancestral PrRP. Thus, the original role of PrRP
and PrRP2 would be the regulation of GH release and feed-
ing rather than PRL release. However, the physiological roles of
PrRP on the releases of PRL and GH, feeding behavior, and stress
response in non-mammalian vertebrates have not been clarified
(Table 2) because their PrRPs were recently predicted. Informa-
tion regarding the effect of PrRP2 on the endocrine system and
stress response, which have been investigated in rodents, is also
insufficient. To acquire a clearer understanding of the biological
and physiological roles of PrRP and PrRP2, future investigations
should focus on the physiological roles of PrRP and PrRP2 in non-
mammalian vertebrates. Such studies should reveal the evolution
of the PrRP family in vertebrates.
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